Clinical Trial Update: SSNHL in Head & Neck Cancer Patients [NA]

View source ↗

Summary

A clinical trial investigating sudden sensorineural hearing loss in head and neck cancer patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sudden Sensorineural Hearing Loss

Snippet

Sponsor: Nova Scotia Health Authority | Conditions: Hearing Loss | NA | Status: WITHDRAWN